BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25404203)

  • 1. Understanding Patient Preferences in Medication Nonadherence: A Review of Stated Preference Data.
    Laba TL; Essue B; Kimman M; Jan S
    Patient; 2015 Oct; 8(5):385-95. PubMed ID: 25404203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.
    Johnson FR; Ozdemir S; Manjunath R; Hauber AB; Burch SP; Thompson TR
    Med Care; 2007 Jun; 45(6):545-52. PubMed ID: 17515782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eliciting Preferences in Dentistry with Multiattribute Stated Preference Methods: A Systematic Review.
    Barber S; Pavitt S; Khambay B; Bekker H; Meads D
    JDR Clin Trans Res; 2018 Oct; 3(4):326-335. PubMed ID: 30931788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Patients' preferences in the medicamentous treatment of diabetes mellitus type 2: A systematic classification and meta-comparison of patient preference studies].
    Mühlbacher AC; Kaczynski A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Apr; 58(4-5):452-66. PubMed ID: 25687713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Patient Preferences for Osteoporosis Drug Treatment.
    Hiligsmann M; Bours SP; Boonen A
    Curr Rheumatol Rep; 2015 Sep; 17(9):61. PubMed ID: 26286178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding rational non-adherence to medications. A discrete choice experiment in a community sample in Australia.
    Laba TL; Brien JA; Jan S
    BMC Fam Pract; 2012 Jun; 13():61. PubMed ID: 22715853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences and Stated Adherence for Antibiotic Treatment of Cystic Fibrosis Pseudomonas Infections.
    Mohamed AF; Johnson FR; Balp MM; Calado F
    Patient; 2016 Feb; 9(1):59-67. PubMed ID: 25838082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences.
    Mühlbacher A; Bethge S
    Eur J Health Econ; 2016 Dec; 17(9):1125-1140. PubMed ID: 26682548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to improve adherence to medications for cardiovascular diseases in socioeconomically disadvantaged populations: a systematic review.
    Laba TL; Bleasel J; Brien JA; Cass A; Howard K; Peiris D; Redfern J; Salam A; Usherwood T; Jan S
    Int J Cardiol; 2013 Sep; 167(6):2430-40. PubMed ID: 23415168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of patient perceptions and preferences for osteoporosis medication on adherence behavior in the Denosumab Adherence Preference Satisfaction study.
    Kendler DL; Macarios D; Lillestol MJ; Moffett A; Satram-Hoang S; Huang J; Kaur P; Tang ET; Wagman RB; Horne R
    Menopause; 2014 Jan; 21(1):25-32. PubMed ID: 23676636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Patient-Centered Care by Assessing Patient Preferences for Multiple Sclerosis Disease-Modifying Agents: A Stated-Choice Experiment.
    Carlin CS; Higuera L; Anderson S
    Perm J; 2017; 21():16-102. PubMed ID: 28406788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Review of Discrete-Choice Experiments and Conjoint Analysis Studies in People with Multiple Sclerosis.
    Webb EJD; Meads D; Eskyte I; King N; Dracup N; Chataway J; Ford HL; Marti J; Pavitt SH; Schmierer K; Manzano A
    Patient; 2018 Aug; 11(4):391-402. PubMed ID: 29313265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strategy based on patient preference improves the adherence and outcomes of phosphate binders in hemodialysis
.
    Arenas Jiménez MD; Parra Moncasi E; Álvarez-Ude Cotera F
    Clin Nephrol; 2017 Jul; 88(1):1-11. PubMed ID: 28438255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
    Poulos C; Kinter E; Yang JC; Bridges JF; Posner J; Reder AT
    Patient; 2016 Apr; 9(2):171-80. PubMed ID: 26259849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician and patient preferences for dosing options in migraine prevention.
    Cowan R; Cohen JM; Rosenman E; Iyer R
    J Headache Pain; 2019 May; 20(1):50. PubMed ID: 31072307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of medication adherence in children and adults with ADHD.
    Adler LD; Nierenberg AA
    Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding medication compliance and persistence from an economics perspective.
    Elliott RA; Shinogle JA; Peele P; Bhosle M; Hughes DA
    Value Health; 2008; 11(4):600-10. PubMed ID: 18194403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One size does not fit all: HIV testing preferences differ among high-risk groups in Northern Tanzania.
    Ostermann J; Njau B; Mtuy T; Brown DS; Mühlbacher A; Thielman N
    AIDS Care; 2015; 27(5):595-603. PubMed ID: 25616562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trouble getting started: predictors of primary medication nonadherence.
    Fischer MA; Choudhry NK; Brill G; Avorn J; Schneeweiss S; Hutchins D; Liberman JN; Brennan TA; Shrank WH
    Am J Med; 2011 Nov; 124(11):1081.e9-22. PubMed ID: 22017787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.